BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27815426)

  • 1. GATA1-Deficient Dendritic Cells Display Impaired CCL21-Dependent Migration toward Lymph Nodes Due to Reduced Levels of Polysialic Acid.
    Scheenstra MR; De Cuyper IM; Branco-Madeira F; de Bleser P; Kool M; Meinders M; Hoogenboezem M; Mul E; Wolkers MC; Salerno F; Nota B; Saeys Y; Klarenbeek S; van IJcken WF; Hammad H; Philipsen S; van den Berg TK; Kuijpers TW; Lambrecht BN; Gutiérrez L
    J Immunol; 2016 Dec; 197(11):4312-4324. PubMed ID: 27815426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21.
    Hansen M; Met Ö; Larsen NB; Rosenkilde MM; Andersen MH; Svane IM; Hjortø GM
    Cytotherapy; 2016 Sep; 18(9):1187-96. PubMed ID: 27424146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAMP1/YitFc mice develop ileitis via loss of CCL21 and defects in dendritic cell migration.
    Mikulski Z; Johnson R; Shaked I; Kim G; Nowyhed H; Goodman W; Chodaczek G; Pizarro TT; Cominelli F; Ley K
    Gastroenterology; 2015 Apr; 148(4):783-793.e5. PubMed ID: 25620669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL21 is sufficient to mediate DC migration, maturation and function in the absence of CCL19.
    Britschgi MR; Favre S; Luther SA
    Eur J Immunol; 2010 May; 40(5):1266-71. PubMed ID: 20201039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells.
    Schumann K; Lämmermann T; Bruckner M; Legler DF; Polleux J; Spatz JP; Schuler G; Förster R; Lutz MB; Sorokin L; Sixt M
    Immunity; 2010 May; 32(5):703-13. PubMed ID: 20471289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling.
    Tal O; Lim HY; Gurevich I; Milo I; Shipony Z; Ng LG; Angeli V; Shakhar G
    J Exp Med; 2011 Sep; 208(10):2141-53. PubMed ID: 21930767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intralymphatic CCL21 Promotes Tissue Egress of Dendritic Cells through Afferent Lymphatic Vessels.
    Russo E; Teijeira A; Vaahtomeri K; Willrodt AH; Bloch JS; Nitschké M; Santambrogio L; Kerjaschki D; Sixt M; Halin C
    Cell Rep; 2016 Feb; 14(7):1723-1734. PubMed ID: 26876174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue inflammation modulates gene expression of lymphatic endothelial cells and dendritic cell migration in a stimulus-dependent manner.
    Vigl B; Aebischer D; Nitschké M; Iolyeva M; Röthlin T; Antsiferova O; Halin C
    Blood; 2011 Jul; 118(1):205-15. PubMed ID: 21596851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells.
    Marsland BJ; Bättig P; Bauer M; Ruedl C; Lässing U; Beerli RR; Dietmeier K; Ivanova L; Pfister T; Vogt L; Nakano H; Nembrini C; Saudan P; Kopf M; Bachmann MF
    Immunity; 2005 Apr; 22(4):493-505. PubMed ID: 15845453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ CD25+ regulatory T cells prevent type 1 diabetes preceded by dendritic cell-dominant invasive insulitis by affecting chemotaxis and local invasiveness of dendritic cells.
    Lee MH; Lee WH; Todorov I; Liu CP
    J Immunol; 2010 Aug; 185(4):2493-501. PubMed ID: 20639483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft Site Microenvironment Determines Dendritic Cell Trafficking Through the CCR7-CCL19/21 Axis.
    Hua J; Stevenson W; Dohlman TH; Inomata T; Tahvildari M; Calcagno N; Pirmadjid N; Sadrai Z; Chauhan SK; Dana R
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1457-67. PubMed ID: 27031839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polysialic acid is required for neuropilin-2a/b-mediated control of CCL21-driven chemotaxis of mature dendritic cells and for their migration in vivo.
    Rey-Gallardo A; Delgado-Martín C; Gerardy-Schahn R; Rodríguez-Fernández JL; Vega MA
    Glycobiology; 2011 May; 21(5):655-62. PubMed ID: 21199821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four-and-a-half LIM domain protein 2 is a novel regulator of sphingosine 1-phosphate receptor 1 in CCL19-induced dendritic cell migration.
    König K; Diehl L; Rommerscheidt-Fuss U; Golletz C; Quast T; Kahl P; Kolanus W; Knolle P; Buettner R; Heukamp LC
    J Immunol; 2010 Aug; 185(3):1466-75. PubMed ID: 20592280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysialylated neuropilin-2 enhances human dendritic cell migration through the basic C-terminal region of CCL21.
    Rey-Gallardo A; Escribano C; Delgado-Martín C; Rodriguez-Fernández JL; Gerardy-Schahn R; Rutishauser U; Corbi AL; Vega MA
    Glycobiology; 2010 Sep; 20(9):1139-46. PubMed ID: 20488940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lymphoid chemokine CCL21 triggers LFA-1 adhesive properties on human dendritic cells.
    Eich C; de Vries IJ; Linssen PC; de Boer A; Boezeman JB; Figdor CG; Cambi A
    Immunol Cell Biol; 2011 Mar; 89(3):458-65. PubMed ID: 20805842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of CCL19 by DC-Lamp+ mature dendritic cells in human lymph node versus chronically inflamed skin.
    Katou F; Ohtani H; Nakayama T; Nagura H; Yoshie O; Motegi K
    J Pathol; 2003 Jan; 199(1):98-106. PubMed ID: 12474232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcoplasmic reticulum Ca(2+) ATPase 2 (SERCA2) reduces the migratory capacity of CCL21-treated monocyte-derived dendritic cells.
    Hong CY; Lee HJ; Choi NR; Jung SH; Vo MC; Hoang MD; Kim HJ; Lee JJ
    Exp Mol Med; 2016 Aug; 48(8):e253. PubMed ID: 27538371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of polysialic acid with CCL21 regulates the migratory capacity of human dendritic cells.
    Bax M; van Vliet SJ; Litjens M; García-Vallejo JJ; van Kooyk Y
    PLoS One; 2009 Sep; 4(9):e6987. PubMed ID: 19750015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syndecan-1 regulates dendritic cell migration in cutaneous hypersensitivity to haptens.
    Averbeck M; Kuhn S; Bühligen J; Götte M; Simon JC; Polte T
    Exp Dermatol; 2017 Nov; 26(11):1060-1067. PubMed ID: 28453867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal dendritic cell mobilization to lymph nodes under conditions of severe lymphatic hypoplasia.
    Platt AM; Rutkowski JM; Martel C; Kuan EL; Ivanov S; Swartz MA; Randolph GJ
    J Immunol; 2013 May; 190(9):4608-20. PubMed ID: 23530147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.